Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2001-10-19
pubmed:abstractText
Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLE) constitute with methicillin-resistant Staphylococcus aureus the main multiresistant bacteria recovered in French hospitals. Our objectives were to evaluate these ESBLE diffusion in our teaching hospital and to follow their incidence during a 16-month period, whereas a control programme (barrier precautions) had been implemented in the beginning of 1999. This study was conducted in a teaching hospital containing 1800 beds, from February 1999 to May 2000. All ESBLE isolated in clinical or screening samples were included. Duplicates (same bacteria in the same patient) were excluded. The detection of the ESBL was performed with the double-disk diffusion test. Incidence densities were determined with their 95% confidence interval (CI95%). Their evolution by four-month period was evaluated with the chi-square test for trend. During the 16-month period, 229 ESBLE were isolated. The incidence was 0.35 per 1000 patient-days (PD) (CI95% = [0.30-0.40]) for the whole hospital. It was 0.47/1000 PD (CI95% = [0.38-0.56]) in medical wards, 0.29/1000 PD (CI95% = [0.20-0.38]) in surgical wards and 1.32/1000 PD (CI95% = [0.90-1.74]) in intensive care units. Enterobacter aerogenes strains represented more than 75% of all ESBLE, whereas Klebsiella pneumoniae stains represented only 8.6%. During the study, the incidence of ESBLE and the proportion of strains acquired in our hospital decreased significantly (p < 0.0001 and p < 0.001 respectively). Indeed, between the first eight-month period and the last one, the incidence of ESBLE acquired in our hospital decreased by 55%, whereas the incidence of imported strains increased slightly. This study shows that the diffusion of ESBLE concerns the entire hospital. The implementation of a control programme of the spread of multiresistant bacteria allowed us to reduce significantly the incidence of ESBLE. This incidence seemed to be stable for several months. The implementation of a policy which restricts antimicrobial use would allow us to complete the the efficacy of barrier precautions.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0369-8114
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
515-21
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11642012-Academic Medical Centers, pubmed-meshheading:11642012-Aged, pubmed-meshheading:11642012-Bacterial Proteins, pubmed-meshheading:11642012-Carrier State, pubmed-meshheading:11642012-Community-Acquired Infections, pubmed-meshheading:11642012-Cross Infection, pubmed-meshheading:11642012-Drug Resistance, Multiple, pubmed-meshheading:11642012-Enterobacter aerogenes, pubmed-meshheading:11642012-Enterobacteriaceae, pubmed-meshheading:11642012-Enterobacteriaceae Infections, pubmed-meshheading:11642012-Female, pubmed-meshheading:11642012-France, pubmed-meshheading:11642012-Hospital Departments, pubmed-meshheading:11642012-Humans, pubmed-meshheading:11642012-Incidence, pubmed-meshheading:11642012-Klebsiella, pubmed-meshheading:11642012-Male, pubmed-meshheading:11642012-Middle Aged, pubmed-meshheading:11642012-Prospective Studies, pubmed-meshheading:11642012-Risk Factors, pubmed-meshheading:11642012-beta-Lactam Resistance, pubmed-meshheading:11642012-beta-Lactamases
pubmed:year
2001
pubmed:articleTitle
[Spread of Enterobacteriaceae producing broad-spectrum beta-lactamase and the development of their incidence over a 16-month period in a university hospital center].
pubmed:affiliation
Laboratoire de bactériologie-hygiène, CHU Amiens, hôpital Nord, place Victor Pauchet, 80054 Amiens, France. eveillard.matthieu@chu-amiens.fr
pubmed:publicationType
Journal Article, English Abstract